Olga V Fedorova

Title: Olga V Fedorova: Innovator in Cardiovascular Research

Introduction

Olga V Fedorova is a prominent inventor based in Bel Air, MD (US). She has made significant contributions to the field of cardiovascular research, particularly through her innovative work on antibodies that target marinobufagenin. Her research has the potential to impact the diagnosis and treatment of various cardiovascular diseases.

Latest Patents

Olga V Fedorova holds a patent for "Anti-marinobufagenin antibodies and methods for their use." This patent describes deposited hybridoma cell lines and the monoclonal antibodies produced by these hybridomas, along with antigen binding fragments thereof. These monoclonal antibodies specifically bind to marinobufagenin, and the patent encompasses their use in detecting the presence of marinobufagenin in biological samples. Additionally, the patent outlines methods for using these antibodies as prophylactic, therapeutic, and diagnostic agents for cardiovascular diseases, including essential hypertension and myocardial fibrosis.

Career Highlights

Fedorova's career is marked by her dedication to advancing medical science through innovative research. She works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has garnered attention for its potential applications in improving cardiovascular health.

Collaborations

Olga has collaborated with notable colleagues in her field, including Alexei Bagrov and Edward G Lakatta. These collaborations have further enriched her research and contributed to the development of her patented technologies.

Conclusion

Olga V Fedorova is a trailblazer in the field of cardiovascular research, with her innovative patents paving the way for new diagnostic and therapeutic approaches. Her work exemplifies the impact of scientific innovation on healthcare.